• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症药物研发与治疗的挑战与解决方案概览。

A snapshot of challenges and solutions in cancer drug development and therapy.

机构信息

Division of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.

Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, Tennessee, USA.

出版信息

Clin Pharmacol Ther. 2014 Apr;95(4):341-6. doi: 10.1038/clpt.2014.15.

DOI:10.1038/clpt.2014.15
PMID:24646480
Abstract

Cancer chemotherapy has transitioned from the use of cytotoxic drugs to the era of agents with an apparent selectivity for a cancer-specific target. The past decade has provided evidence that therapy with such agents can be curative in subsets of patients. It is anticipated that incorporation of pharmacological principles for novel therapeutics will result in further refinement of outcome measures as well as the discovery of new treatment modalities for multiple malignant diseases.

摘要

癌症化疗已经从使用细胞毒性药物过渡到了针对特定癌症靶点的药物时代。过去十年的证据表明,此类药物的治疗在某些患者亚群中可以达到治愈效果。预计将药理学原理应用于新型治疗方法将进一步完善疗效评估指标,并为多种恶性疾病发现新的治疗方法。

相似文献

1
A snapshot of challenges and solutions in cancer drug development and therapy.癌症药物研发与治疗的挑战与解决方案概览。
Clin Pharmacol Ther. 2014 Apr;95(4):341-6. doi: 10.1038/clpt.2014.15.
2
Molecularly targeted cancer therapy: some lessons from the past decade.分子靶向癌症治疗:过去十年的一些经验教训。
Trends Pharmacol Sci. 2014 Jan;35(1):41-50. doi: 10.1016/j.tips.2013.11.004. Epub 2013 Dec 19.
3
[New anticancer drugs: much ado about nothing?].[新型抗癌药物:小题大做?]
Rev Med Suisse. 2014 Apr 9;10(425):788, 790-3.
4
The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.基于个性化基因组的癌症分子疗法的机遇与挑战:靶点、技术和分子伴侣
Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S45-56. doi: 10.1007/s00280-003-0593-0. Epub 2003 Jun 18.
5
Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunities.通过定量转化和临床药理学优化肿瘤治疗:挑战与机遇
Clin Pharmacol Ther. 2015 Jan;97(1):37-54. doi: 10.1002/cpt.7. Epub 2014 Dec 9.
6
Challenges of developing therapeutics that target signal transduction in patients with gynecologic and other malignancies.开发针对妇科及其他恶性肿瘤患者信号转导的治疗方法所面临的挑战。
J Clin Oncol. 2003 May 15;21(10 Suppl):175s-186s. doi: 10.1200/JCO.2003.01.146.
7
Mathematical modeling in cancer drug discovery.癌症药物研发中的数学建模
Drug Discov Today. 2014 Feb;19(2):145-50. doi: 10.1016/j.drudis.2013.06.015. Epub 2013 Jul 4.
8
Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.纳米医学用于靶向癌症治疗:克服耐药性。
Drug Resist Updat. 2011 Jun;14(3):150-63. doi: 10.1016/j.drup.2011.01.003. Epub 2011 Feb 16.
9
Targeted cancer therapies: the future of cancer treatment.靶向癌症疗法:癌症治疗的未来。
Acta Biomed. 2012 Dec;83(3):220-33.
10
Targeted cancer therapy: conferring specificity to cytotoxic drugs.靶向癌症治疗:赋予细胞毒性药物特异性。
Acc Chem Res. 2008 Jan;41(1):98-107. doi: 10.1021/ar700108g. Epub 2007 Aug 18.

引用本文的文献

1
Pharmacogenomic biomarkers as inclusion criteria in clinical trials of oncology-targeted drugs: a mapping of ClinicalTrials.gov.药物基因组生物标志物作为肿瘤靶向药物临床试验的纳入标准:ClinicalTrials.gov数据库的映射分析
Genet Med. 2016 Aug;18(8):796-805. doi: 10.1038/gim.2015.165. Epub 2015 Dec 17.
2
Network Analysis of Cancer-focused Association Network Reveals Distinct Network Association Patterns.癌症相关网络的网络分析揭示了不同的网络关联模式。
Cancer Inform. 2014 Oct 16;13(Suppl 3):45-51. doi: 10.4137/CIN.S14033. eCollection 2014.
3
Novel medicines and strategies in cancer treatment and prevention.
癌症治疗与预防中的新型药物和策略。
Biomed Res Int. 2014;2014:474078. doi: 10.1155/2014/474078. Epub 2014 May 27.